ASRS
VERV

Arizona State Retirement System’s Verve Therapeutics VERV Stock Holding History

Arizona State Retirement System’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,827
Closed -$189K – 2128
2025
Q2 		$189K Sell
16,827
-1,358
-7% -$7.74K ﹤0.01% 1922
2025
Q1 		$83.1K Sell
18,185
-1,408
-7% -$9.43K ﹤0.01% 2054
2024
Q4 		$111K Buy
19,593
+2,669
+16% +$15.1K ﹤0.01% 2079
2024
Q3 		$81.9K Buy
16,924
+538
+3% +$3.13K ﹤0.01% 2131
2024
Q2 		$80K Buy
16,386
+2,019
+14% +$12.7K ﹤0.01% 2081
2024
Q1 		$191K Sell
14,367
-993
-6% -$13.2K ﹤0.01% 1945
2023
Q4 		$214K Buy
15,360
+3,017
+24% +$37.4K ﹤0.01% 1914
2023
Q3 		$164K Buy
12,343
+1,054
+9% +$17K ﹤0.01% 1963
2023
Q2 		$212K Buy
+11,289
New +$188K ﹤0.01% 1929
2022
Q4 		– Sell
-8,746
Closed -$300K – 2260
2022
Q3 		$300K Buy
+8,746
New +$279K ﹤0.01% 1641

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Arizona State Retirement System's VERV Position: Q3 2025 in Review

Arizona State Retirement System sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 16,827 shares — an estimated $189K sold.

Arizona State Retirement System first reported a position in VERV in Q3 2022 and held it in 10 quarters. The position peaked at $300K in Q3 2022. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Arizona State Retirement System reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Arizona State Retirement System sold 16,827 Verve Therapeutics shares in Q3 2025, an estimated $189K.
  • Arizona State Retirement System first reported a position in Verve Therapeutics in Q3 2022 and held it in 10 quarters.
  • Arizona State Retirement System's Verve Therapeutics position peaked at $300K in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Arizona State Retirement System's 13F filing for Q3 2025, filed 3 Nov 2025.